You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

DUBLIN, Sept. 30, 2020 /PRNewswire/ -- The "Global Gynecology Partnering 2010-2020: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering. Global Gynecology Partnering 2010-2020: Deal trends, players and financials provides the full collection of Gynecology disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element. The report takes readers through the comprehensive Gynecology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Gynecology deals. The report presents financial deal terms values for Gynecology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals. In addition, a comprehensive appendix is provided with each report of all Gynecology partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. The report also includes numerous tables and figures that illustrate the trends and activities in Gynecology partnering and dealmaking since 2010. In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Gynecology technologies and products. Report scopeGlobal Gynecology Partnering 2010 to 2020 includes: Trends in Gynecology dealmaking in the biopharma industry since 2010 Analysis of Gynecology deal structure Access to headline, upfront, milestone and royalty data Access to hundreds of Gynecology deal contract documents Comprehensive access to over 350 Gynecology deal records The leading Gynecology deals by value since 2010 Most active Gynecology dealmakers since 2010 Available deals and contracts are listed by: Headline value Upfront payment value Royalty rate value Stage of development at signing Deal component type Technology type Specific therapy indication Key Topics Covered: Executive SummaryChapter 1 - IntroductionChapter 2 - Trends in Gynecology dealmaking2.1. Introduction2.2. Gynecology partnering over the years2.3. Gynecology partnering by deal type2.4. Gynecology partnering by industry sector2.5. Gynecology partnering by stage of development2.6. Gynecology partnering by technology type2.7. Gynecology partnering by therapeutic indicationChapter 3 -Financial deal terms for Gynecology partnering3.1. Introduction3.2. Disclosed financials terms for Gynecology partnering3.3. Gynecology partnering headline values3.4. Gynecology deal upfront payments3.5. Gynecology deal milestone payments3.6. Gynecology royalty ratesChapter 4 - Leading Gynecology deals and dealmakers4.1. Introduction4.2. Most active in Gynecology partnering4.3. List of most active dealmakers in Gynecology4.4. Top Gynecology deals by valueChapter 5 - Gynecology contract document directory5.1. Introduction5.2. Gynecology partnering deals where contract document availableChapter 6 - Gynecology dealmaking by therapeutic target6.1. Introduction6.2. Deals by Gynecology therapeutic targetAppendicesAppendix 1 - Directory of Gynecology deals by company A-Z 2010 to 2020Appendix 2 - Directory of Gynecology deals by deal type 2010 to 2020Appendix 3 - Directory of Gynecology deals by stage of development 2010 to 2020Appendix 4 - Directory of Gynecology deals by technology type 2010 to 2020Companies Mentioned 23andMe Abbvie Accord Healthcare Acerus Advaxis Adynxx AEterna Zentaris Agency for Healthcare Research and Quality Agile Therapeutics AirStrip Technologies Albion Allakos Alvogen American Dental Association Amgen Amos Gazit ANI Pharmaceuticals ApolloBio Arbor Pharmaceuticals Arc Medical Design Ascend Therapeutics ASKA Pharmaceuticals Aspen Dental ASPiRA Labs AstraZeneca Austrian Research Promotion Agency Avion Pharmaceuticals Aytu BioScience Back Bay Scientific Bavarian Nordic Bayer Bayer Healthcare Baylor College of Medicine Beckman Coulter Beijing Genomics Institute (BGI) Besins Healthcare Bill and Melinda Gates Foundation Biocon Biomnis Biotech Inc BL&H Bluebird Bio BMV Medica Boston Scientific Bristol-Myers Squibb California Institute for Biomedical Research Celmatix Center for Human Genetics and Laboratory Medicine Chinese Academy of Sciences Chun Fo Pharmaceutical Cipla Medpro ClearSpec Clinigen CNC Biotech Co-Diagnostics Cocrystal Pharma CommonSense Common Sense Consortia Health Control Flo Medical Cooper Companies Coriell Life Sciences CR Pharma CVC Capital Partners Cynosure Debiopharm DIAsource ImmunoAssays Dilafor Distal Access Duchesnay Duke University DySIS Medical Easton Pharmaceuticals Egalet El.En Elanix Biotechnologies EMD Serono Emory University EndoCeutics European Board and College of Obstetrics and Gynaecology European Organization for Research and Treatment of Cancer European Union Regional Development Fund Evestra Evotec Expedeon Famy Care Ferring Pharmaceuticals Flo Health Fogarty Institute for Innovation Foresee Pharmaceuticals Fougera Pharmaceuticals Fuji Pharma Genea Biomedx Genoma Genome Medical German Cancer Research Center Gilead Sciences GlaxoSmithKline GOG Foundation Golden Valley Development Good Start Genetics Grunenthal Guided Therapeutics Gynica Halt Medical Hammock Pharmaceuticals HealthNet Helix Helix BioPharma Hologic Hookipa Biotech Hope Medicine HTG Molecular Diagnostics Igantia Therapeutics iGenomix Illumina Imaxio IncellDx InnerOptic Technology Innovus Pharmaceuticals Inovio Pharmaceuticals Intuitive Surgical INVO Bioscience Irvine Scientific IsoRay ITEM Medical Technologies IviGen Janssen Pharmaceuticals Johns Hopkins University Joylux Karolinska Institute Kissei Pharmaceutical Kite Pharma Knight Therapeutics Kyoto University Laboratory Corporation of America Laccure Lake Consumer Products Lee's Pharmaceutical LFB Biotechnologies LifeCodexx Lumara Health Lumir Lab Massachusetts General Hospital McKesson MD Anderson Cancer Center MDNA Life Sciences Meda MEDCIS Pathlabs Medical University of South Carolina Medical University South Carolina MediCare International MediGene MedikorPharma MedImmune Medinova MedTech For Solutions Medtronic Mel-Mont Medical MenoGeniX Merck and Co Merck KGaA Merck Serono Merus Labs International MilanaPharm Millendo Therapeutics Ministry of Health (Turkey) Mission Pharmacal Mithra Pharmaceuticals Mitsubishi Tanabe Pharma Morphic Therapeutic MSD Mundipharma MyBiotics Pharma Mylan Laboratories Myovant Sciences Myrtle Potter & Company Naka International Natera National Institute for Public Health and the Environment National Institute on Aging National Institutes of Health Neoteric Technology NextGen LifeLabs Nobelpharma Norgine Northwestern University Novation Noven Pharmaceuticals Novogene NX Prenatal OBP Medical ObsEva Olympus OncoSec Medical Oncotest Oral Cancer Foundation OvaGene Oncology Oxford MEstar Patient-Centered Primary Care Collaborative (PCPCC) PaxGenBio PCOS Challenge PCOS Diva PDS Biotechnology Peking University Perinatal Quality Foundation PerkinElmer Perrigo Pfizer PharmaJet Pharmanest Pharma Solutions Peru Psyche Systems Radius Health Rebiotix Recipharm Reproductive Health Science Reprogenetics rEVO Biologics Roche Romark Laboratories Royal Philips Electronics Sanofi Sanofi-Pasteur Scholar Rock Selecta Biosciences Shandong Yaohua Medical Instrument Shenghuo Medical Shionogi Shire Pharmaceuticals Sims IVF Sincopharm Sirio Pharma Skolkovo Foundation Smith & Nephew Smiths Medical Society For Reproductive Investigation Society of Gynecologic Oncology SRI International Starpharma Strainprint Technologies Sun Pharmaceutical Surgicorp Syn-The-All Pharmaceutical SynteractHCR Takeda Pharmaceutical Tec-Pharma Telenatal Tesaro Tessa Therapeutics Teva Pharmaceutical Industries Teva Pharmaceuticals USA Theramex TherapeuticsMD Thermo Fisher Scientific Transgene Trimel Pharmaceuticals Trivector Biomed Trophogen twoXAR Unified Women's Clinical Research University College Dublin Conway Institute University Magna Graecia University of Hong Kong University of Michigan University of Oxford University of Siena Upsher-Smith Vaccibody Valeo Pharma Vertical Pharmaceuticals Viramal Virtus Health VolitionRX Wayne State University Wellmed Windsor Pharmaceuticals Womens Choice Pharmaceuticals Wuxi Apptec Laboratory Services Xbrane Bioscience Xisle Pharma Ventures Trust ZenTech Zhengzhou University Zoetis For more information about this report visit https://www.researchandmarkets.com/r/brdvyn Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

Answer: Global Gynecology Partnering Report 2020: Full Collection of 350 Deals Signed Between the World's Pharma and Biotech Companies Since 2010